Shengyuan Luo

5PUBLICATIONS
29CO-AUTHORS
HaematologyNanoelectronicsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 04, 2022
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19.

Shengyuan Luo, Alexi Vasbinder, Jeanne M Du-Fay-de-Lavallaz

|Dec 31, 2020
NAT8 Variants, N-Acetylated Amino Acids, and Progression of CKD.

Shengyuan Luo, Aditya Surapaneni, Zihe Zheng

|Jun 16, 2018
Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.

Shengyuan Luo, Josef Coresh, Adrienne Tin

Pageof 1